Clinical trial
Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)
NCT00482417 · Merck Sharp & Dohme LLC, Industry · Completed
Key facts
| NCT number | NCT00482417 |
|---|---|
| Title | Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017) |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Rheumatoid Arthritis |
| Intervention type | Drug |
| Interventions | MK0359 |
| Enrollment | 11 |
| Start date | Dec 1, 2002 |
| Primary completion | May 1, 2003 |
| Completion | May 1, 2003 |
| First posted | Jun 5, 2007 |
| Last update posted | Nov 20, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: